{
    "nctId": "NCT02436772",
    "briefTitle": "Utilization of the OncoCEE\u2122 Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC",
    "officialTitle": "Utilization of the OncoCEE\u2122 Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC",
    "overallStatus": "COMPLETED",
    "conditions": "Metastatic Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 74,
    "primaryOutcomeMeasure": "Concordance with standard test",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Current patient at participating clinic\n* Metastatic breast cancer diagnosis\n* 18 years of age or older\n\nExclusion Criteria:\n\nNone",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}